<- Go Home
GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.
Market Cap
$3.6B
Volume
814.8K
Cash and Equivalents
$74.1M
EBITDA
$29.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$243.4M
Profit Margin
67.18%
52 Week High
$127.36
52 Week Low
$28.86
Dividend
N/A
Price / Book Value
13.09
Price / Earnings
2.6K
Price / Tangible Book Value
41.45
Enterprise Value
$3.6B
Enterprise Value / EBITDA
98.55
Operating Income
$7.1M
Return on Equity
0.60%
Return on Assets
1.05
Cash and Short Term Investments
$134.6M
Debt
$114.4M
Equity
$277.1M
Revenue
$362.3M
Unlevered FCF
$22.1M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium